Continuous Cervical Erector Spinae Plane Block Versus Interscalene Nerve Block in Shoulder Arthroscopic Surgery
1 other identifier
interventional
165
1 country
1
Brief Summary
Shoulder arthroscopic surgery is associated with moderate to severe postoperative pain, which may hinder early mobilization and functional recovery. Interscalene block (ISB) is commonly used to provide effective analgesia but is frequently associated with hemidiaphragmatic paralysis due to phrenic nerve involvement. Cervical erector spinae plane block (ESPB) has been proposed as an alternative regional technique that may provide analgesia while reducing respiratory-related adverse effects. This randomized controlled trial aims to compare the analgesic efficacy and safety of cervical ESPB versus continuous ISB in patients undergoing shoulder arthroscopic surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 8, 2026
CompletedStudy Start
First participant enrolled
January 15, 2026
CompletedFirst Posted
Study publicly available on registry
January 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2028
January 27, 2026
January 1, 2026
2 years
January 8, 2026
January 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative pain intensity within postoperative 24 hours
Postoperative pain intensity will be assessed using a 0-10 visual analogue scale (VAS) at 2, 6, 12, and 24 hours after surgery.
2 hour, 6 hours, 12 hours, and 24 hours postoperatively
Secondary Outcomes (6)
Motor blockade severity
Up to 48 hours postoperatively
analgesic consumption
48 hours
Adverse events
7 days
Duration of motor blockade
Up to 48 hours postoperatively
Sensory blockade distribution
Up to 48 hours postoperatively
- +1 more secondary outcomes
Study Arms (3)
Continuous Cervical Erector Spinae Plane Block
EXPERIMENTALParticipants will receive an ultrasound-guided continuous cervical erector spinae plane block with perineural catheter placement as part of a standardized multimodal analgesia regimen for shoulder arthroscopic surgery. Postoperative analgesia will be provided via continuous local anesthetic infusion through the catheter per institutional protocol.
Continuous Interscalene Block
ACTIVE COMPARATORParticipants will receive an ultrasound-guided continuous interscalene block with perineural catheter placement as part of a standardized multimodal analgesia regimen for shoulder arthroscopic surgery. Postoperative analgesia will be provided via continuous local anesthetic infusion through the catheter per institutional protocol.
Single-Shot Interscalene Block
OTHERObservational
Interventions
An ultrasound-guided cervical erector spinae plane block with catheter placement will be performed. Local anesthetic will be administered through the catheter to provide continuous postoperative analgesia according to institutional protocol as part of a standardized multimodal analgesic regimen.
An ultrasound-guided interscalene block with catheter placement will be performed. Local anesthetic will be administered through the catheter to provide continuous postoperative analgesia according to institutional protocol as part of a standardized multimodal analgesic regimen.
Eligibility Criteria
You may qualify if:
- Adult patients scheduled for elective shoulder arthroscopic surgery
You may not qualify if:
- Contraindications to regional analgesia
- BMI \>40
- ASA physical status IV
- history of drug or opioid abuse
- preoperative upper limb motor impairment
- postoperative ventilator support or ICU admission
- Inability to provide self-reported pain assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Cheng Kung University Hospital
Tainan, 704, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 8, 2026
First Posted
January 27, 2026
Study Start
January 15, 2026
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
January 31, 2028
Last Updated
January 27, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share